Delivery Order SPE2DB20D2014-SPE2DB25FA24U
Award Date
11/1/24
Potential Completion Date
11/4/24
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $2,325.88 firm fixed price delivery order is for the supply of 4,565,031,462 units of CellCept 500 mg tablets. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA...
This federal contract award is a delivery order valued at $22,275.47, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of CELLCEPT 500 MG TABLET 100S, a prescription medication, with a performance period extending through May 20, 2025. The contract is noted as having no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with a Ceiling Value of $9,218.84. The contract is for the delivery of CELLCEPT 500 MG TABLET 100S and is a Firm Fixed Price contract type. The ultimate completion date for this order is July 9, 2024. Amerisourcebergen Drug Corp holds a larger IDC with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,342.11 firm fixed-price delivery order contract is for the supply of CELLCEPT 500 MG TABLET 100S, a prescription medication. The contract has an ultimate completion date of February 20, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CellCept 500 mg tablets, a medication used to prevent organ rejection in transplant patients. The contract has a firm fixed price of $2,407.68 and a completion date of May 16, 2025. It is not set aside for any particular socioeconomic program. Amerisourcebergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,835.41 firm fixed-price contract is for the delivery of CELLCEPT 500 MG TABLET 500S, a prescription medication. The contract is not set aside and has an ultimate completion date of June 17, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,036.59, is for the delivery of CELLCEPT 500 MG TABLET 500S, a pharmaceutical product, with a completion date of May 20, 2025. The award is not set aside and involves open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,856.14 firm fixed price contract is for the delivery of CELLCEPT 500 MG TABLET 500S, a prescription medication. The contract has a performance period through May 30, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CELLCEPT 500 MG TABLET 500S. The contract is valued at $44,413.54 and has a completion date of September 13, 2024. There is no set-aside designation for this award. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with DLA and the Department of Justice Federal Bureau of Investigation, valued at up...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CELLCEPT 500 MG TABLET 500S, a pharmaceutical product, with a firm fixed price of $6,014.65 and a performance period ending on July 7, 2025. The contract is not set aside and was awarded on July 3, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...